Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth

Title
Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 19, Issue 20, Pages 5613-5625
Publisher
American Association for Cancer Research (AACR)
Online
2013-08-31
DOI
10.1158/1078-0432.ccr-13-1151

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now